Pharmaceutical & Healthcare

Pharmaceutical & Healthcare

The global pharmaceutical market was worth $996bn in 2017, up almost 3% on the year before. The US accounted for 45% of that total, or $453bn. Europe contributed a further 21% (or $214bn), and the rest of the established world for 11% (or $112bn). The fastest growth continues to come from emerging markets, where sales rose by almost 8% in 2017 to $216bn. The top five markets by value are the US, Japan, China, Germany and France. Drug development has slowed dramatically as a result of rising costs. Despite a total R&D budget of $154bn in 2016, only 22 new drugs were approved by the US FDA in 2016, fewer than half the year before.

The World's Leading Pharma Companies in 2021 by healthcare revenues

 Johnson & Johnson $93.8bn  Takeda $31.6bn
 Pfizer $81.3bn  Eli Lilly & Co $28.3bn
 Roche $68.7bn  Bayer $28.2bn
 AbbVie $56.2bn  Gilead Sciences $27.3bn
 Novartis $51.6bn  Amgen $26.0bn
 Merck & Co $48.7bn  Boehringer Ingelheim $24.4bn
 Bristol-Myers Squibb $46.4bn Novo Nordisk $22.4bn
 Glaxo SmithKline $46.0bn BioNTech $22.4bn
 Sanofi $44.7bn Moderna $18.5bn
 AstraZeneca $37.4bn Viatris $17.8bn

Source: company reports

The World's Top 20 Prescription Drugs in 2021 by global sales

Comirnaty $36.8bn Pfizer, BioNTech Opdivo $8.5bn BMS
Humira $20.7bn AbbVie Xarelto $7.5bn Bayer/ J&J
Spikevax $17.75bn Moderna REGEN-COV/Ronapreve $7.5bn Regeneron/Roche
Keytruda $17.2bn Merck Trulicity $6.5bn Eli Lilly
Eliquis $16.7bn BMS / Pfizer Darzalex $6.0bn Janssen / J&J
Revlimid $12.8bn BMS Trikafta/Kaftrio $5.7bn Vertex
Imbruvica $9.8bn AbbVie / J&J Gardasil 9 $5.7bn Merck
Stelara $9.1bn Janssen / J&J Dupixent $5.6bn Sanofi / Regeneron
Eylea $8.9bn Bayer / Regeneron Veklury $5.6bn Gilead Sciences
Biktarvy $8.6bn Gilead Sciences Ibrance $5.4bn Pfizer

Source: Fierce Pharma, company reports

The World's Top Consumer Health Companies in 2017

 Johnson & Johnson $13.6bn  Reckitt Benckiser $6.9bn
 GlaxoSmithKline $10.5bn  Sanofi $4.8bn
 Amway $8.6bn  Herbalife $4.4bn
 Procter & Gamble $7.5bn  Pfizer $3.5bn
 Bayer $7.0bn  Nature's Bounty $3.3bn

Source: Igea, company reports; includes skincare, personal care, oral care, nutritionals, vitamins & hygiene

The World's Top Animal Healthcare Companies in 2014

 Zoetis (ex-Pfizer) 20% global share  Merial (Sanofi) 12%
 Elanco/Novartis AH (Eli Lilly & Co) 15%  Bayer 7%
 Merck & Co 14%  Boehringer Ingelheim 6%

Source: PwC

Top US OTC Products in 2013 by sales

Advil (Pfizer) $615m Alcon (Novartis) $447m Dr Scholl's (Merck*) $370m
Nature Made $596m Claritin (Merck*) $430m Aleve (Bayer) $364m
Mucinex (Reckitt) $578m Depend (Kimberly-Clark) $393m Prilosec OTC (P&G) $359m
Ensure (Abbott) $496m Poise (Kimberly-Clark) $379m 5 Hour Energy $332m

* Bayer from 2014. Source: Main products including biggest variants; IRI 52 wks to Jan 2014 all channels, Drugstorenews

Other companies profiled in Adbrands

 Teva  Astellas Pharma
 Bausch Health (formerly Valeant)  Abbott Laboratories

Gone But Not (Completely) Forgotten

 Warner-Lambert  Smithkline Beecham
 Wyeth  Aventis
 Schering-Plough  Pharmacia

All rights reserved © Mind Advertising Ltd 1998-2022